0001127602-13-019294.txt : 20130604
0001127602-13-019294.hdr.sgml : 20130604
20130604152610
ACCESSION NUMBER: 0001127602-13-019294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20130603
FILED AS OF DATE: 20130604
DATE AS OF CHANGE: 20130604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN IDEC INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERWIN STEPHEN A
CENTRAL INDEX KEY: 0001079462
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 13891052
MAIL ADDRESS:
STREET 1: C/O CELL GENESYS, INC.
STREET 2: 500 FORBES BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-06-03
0000875045
BIOGEN IDEC INC.
BIIB
0001079462
SHERWIN STEPHEN A
BIOGEN IDEC INC.
133 BOSTON POST ROAD
WESTON
MA
02493
1
Common Stock
2013-06-03
4
M
0
12825
59.82
A
15480
D
Common Stock
2013-06-03
4
S
0
3433
232.51
D
12047
D
Common Stock
2013-06-03
4
S
0
9392
233.539
D
2655
D
Stock Option (Right to Buy)
59.82
2013-06-03
4
M
0
12825
0
D
2020-03-22
Common Stock
12825
22175
D
Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
This represents the weighted average price for shares sold at a range between $232.01 (low) and $233.00 (high).
Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
This represents the weighted average price for shares sold at a range between $233.01 (low) and $233.86 (high).
The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010.
Mathew S. Gilman, Attorney in Fact for Stephen Sherwin
2013-06-04
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes,
constitutes and appoints Susan H. Alexander, Matthew S. Gilman, Robert A.
Licht, Robin A. Walker and Marcia J. Gookin as the undersigned's true and
lawful attorney-in-fact, with full power and authority as hereinafter
described on behalf of and in the name, place and stead of the undersigned to:
(1) prepare, execute in the undersigned?s name and on the undersigned?s
behalf, and submit to the U.S. Securities and Exchange Commission
(the ?SEC?) a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required
by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of the SEC;
(2) prepare, execute, acknowledge, deliver and file Forms 3, 4,
and 5 (including any amendments thereto) with respect to the securities
of Biogen Idec Inc., a Delaware corporation (the "Company"), with the
United States Securities and Exchange Commission, any national securities
exchanges and the Company, as considered necessary or advisable under
Section 16(a) of the Securities Exchange Act of 1934 and the rules and
regulations promulgated thereunder, as amended from time to time (the
"Exchange Act");
(3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's
securities from any third party, including brokers, employee benefit
plan administrators and trustees, and the undersigned hereby authorizes
any such person to release any such information to the undersigned and
approves and ratifies any such release of information; and
(4) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the
undersigned in connection with the foregoing.
The undersigned acknowledges that:
(1) this Limited Power of Attorney authorizes, but does not require,
such attorney-in-fact to act in their discretion on information provided
to such attorney-in-fact without independent verification of such
information;
(2) any documents prepared and/or executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Limited Power of Attorney
will be in such form and will contain such information and disclosure
as such attorney-in-fact, in his or her discretion, deems necessary or
desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any
liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned
for any failure to comply with such requirements, or (iii) any obligation
or liability of the undersigned for profit disgorgement under Section 16(b)
of the Exchange Act; and
(4) this Limited Power of Attorney does not relieve the undersigned
from responsibility for compliance with the undersigned's obligations
under the Exchange Act, including without limitation the reporting
requirements under Section 16 of the Exchange Act.
The undersigned hereby gives and grants the foregoing
attorney-in-fact full power and authority to do and perform all
and every act and thing whatsoever requisite, necessary or appropriate
to be done in and about the foregoing matters as fully to all intents
and purposes as the undersigned might or could do if present, hereby
ratifying all that such attorney-in-fact of, for and on behalf of
the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Limited Power of Attorney shall remain in full force
and effect until revoked by the undersigned in a signed writing
delivered to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Limited
Power of Attorney to be executed as of this 29th day of March, 2013.
_/s/ Stephen A. Sherwin__
Signature
Name: Stephen A. Sherwin, MD